Risk of malignancy in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine: The cape town experience

被引：0
|
作者：
Setshedi, M.
Epstein, D.
Hift, R.
Winter, T. A.
Watermeyer, G. A.
机构：
[1] Univ Cape Town, ZA-7700 Rondebosch, South Africa
[2] Groote Schuur Hosp, Cape Town, South Africa
来源：
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2007年 / 97卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：606 / 606
页数：1
相关论文
共 50 条
  • [1] Risk of malignancy in patients with inflammatory Bowel Disease treated with Azathioprine or 6-Mercaptopurine: the Cape Town experience
    Setshedi, Mashiko
    Epstein, David
    Hift, Richard
    Winter, Trevor A.
    Watermeyer, Gill A.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A140 - A141
  • [2] Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Kandiel, A
    Fraser, AG
    Korelitz, BI
    Brensinger, C
    Lewis, JD
    [J]. GUT, 2005, 54 (08) : 1121 - 1125
  • [3] Prognosis for Lymphoma in Patients with Inflammatory Bowel Disease Treated with 6-mercaptopurine or Azathioprine
    Sultan, Keith
    Korelitz, Burton
    Present, Daniel
    Katz, Seymour
    Shapira, Iuliana
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S414 - S415
  • [4] Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease
    Marion, JF
    [J]. INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 116 - 117
  • [5] Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
    Kotlyar, David S.
    Lewis, James D.
    Beaugerie, Laurent
    Tierney, Ann
    Brensinger, Colleen M.
    Gisbert, Javier P.
    Loftus, Edward V., Jr.
    Peyrin-Biroulet, Laurent
    Blonski, Wojciech C.
    Van Domselaar, Manuel
    Chaparro, Maria
    Sandilya, Sandipani
    Bewtra, Meenakshi
    Beigel, Florian
    Biancone, Livia
    Lichtenstein, Gary R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (05) : 847 - U541
  • [6] AZATHIOPRINE, 6-MERCAPTOPURINE, AND INFLAMMATORY BOWEL-DISEASE
    BEAUGERIE, L
    GENDRE, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1990, 14 (03): : 230 - 240
  • [7] Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine
    Su, CY
    Lichtenstein, GR
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 209 - +
  • [8] Tolerability of 6-mercaptopurine in azathioprine intolerant patients with inflammatory bowel disease
    Lees, Charlie
    Maan, Ajeet
    Hansoti, Bhakti
    Penman, Ian D.
    Shand, Alan G.
    Palmer, Kelvin R.
    Arnott, Ian D.
    Satsangi, Jack
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A185 - A185
  • [9] Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
    Kirschner, BS
    [J]. GASTROENTEROLOGY, 1998, 115 (04) : 813 - 821
  • [10] Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
    Gisbert, JP
    Luma, M
    Maté, J
    González-Guijarro, L
    Cara, C
    Pajares, JM
    [J]. MEDICINA CLINICA, 2003, 121 (01): : 1 - 5
12345